BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32773337)

  • 1. Characterization of "suspicious for malignancy" for non-papillary carcinoma diagnoses on thyroid fine-needle aspiration.
    Chowsilpa S; Jones R; Hang JF; Ali SZ
    J Am Soc Cytopathol; 2021; 10(2):148-154. PubMed ID: 32773337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A large series of hyalinizing trabecular tumors: Cytomorphology and ancillary techniques on fine needle aspiration.
    Dell'Aquila M; Gravina C; Cocomazzi A; Capodimonti S; Musarra T; Sfregola S; Fiorentino V; Revelli L; Martini M; Fadda G; Pantanowitz L; Larocca LM; Rossi ED
    Cancer Cytopathol; 2019 Jun; 127(6):390-398. PubMed ID: 31135104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Did Introducing a New Category of Thyroid Tumors (Non-invasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features) Decrease the Risk of Malignancy for the Diagnostic Categories in the Bethesda System for Reporting Thyroid Cytopathology?
    Kopczyński J; Suligowska A; Niemyska K; Pałyga I; Walczyk A; Gąsior-Perczak D; Kowalik A; Hińcza K; Mężyk R; Góźdź S; Kowalska A
    Endocr Pathol; 2020 Jun; 31(2):143-149. PubMed ID: 32236858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The importance of risk of neoplasm as an outcome in cytologic-histologic correlation studies on thyroid fine needle aspiration.
    Chen YH; Partyka KL; Dougherty R; Cramer HM; Wu HH
    Diagn Cytopathol; 2020 Dec; 48(12):1237-1243. PubMed ID: 32716614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of The Bethesda System for Reporting Thyroid Cytopathology.
    Sauter JL; Lehrke H; Zhang X; Al Badri OT; Rodriguez-Gutierrez R; Delivanis DA; Singh Ospina N; Donegan D; Hamidi O; Iñiguez-Ariza N; Sharma A; Kittah NEN; Tamhane SU; Hurtado Andrade MD; Kotwal A; Jenkins SM; Spears G; Rivera M; Dean DS; Henry MR
    Am J Clin Pathol; 2019 Sep; 152(4):502-511. PubMed ID: 31305880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of the Bethesda system for reporting thyroid cytopathology for classification of thyroid nodules: A clinical and cytopathological characteristics in Bhutanese population.
    Choden S; Wangmo C; Maharjan S
    Diagn Cytopathol; 2021 Nov; 49(11):1179-1187. PubMed ID: 34320270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytomorphological and molecular genetic findings in pediatric thyroid fine-needle aspiration.
    Monaco SE; Pantanowitz L; Khalbuss WE; Benkovich VA; Ozolek J; Nikiforova MN; Simons JP; Nikiforov YE
    Cancer Cytopathol; 2012 Oct; 120(5):342-50. PubMed ID: 22605559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytological Diagnosis of Follicular Variant of Papillary Thyroid Carcinoma before and after the Bethesda System for Reporting Thyroid Cytopathology.
    Fazeli R; VandenBussche CJ; Bishop JA; Ali SZ
    Acta Cytol; 2016; 60(1):14-8. PubMed ID: 27007511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Impact of Noninvasive Follicular Variant of Papillary Thyroid Carcinoma on Rates of Malignancy for Fine-Needle Aspiration Diagnostic Categories.
    Strickland KC; Howitt BE; Marqusee E; Alexander EK; Cibas ES; Krane JF; Barletta JA
    Thyroid; 2015 Sep; 25(9):987-92. PubMed ID: 26114752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current status and diagnostic values of the Bethesda system for reporting thyroid cytopathology in a papillary thyroid carcinoma-prevalent area.
    Lee YB; Cho YY; Jang JY; Kim TH; Jang HW; Chung JH; Oh YL; Kim SW
    Head Neck; 2017 Feb; 39(2):269-274. PubMed ID: 27617626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the modification of the diagnostic criteria in the 2017 Bethesda System for Reporting Thyroid Cytopathology: a report of a single institution in Japan.
    Higuchi M; Hirokawa M; Kanematsu R; Tanaka A; Suzuki A; Yamao N; Hayashi T; Kuma S; Miyauchi A
    Endocr J; 2018 Dec; 65(12):1193-1198. PubMed ID: 30282887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Bethesda System for Reporting Thyroid Cytopathology is applicable to frozen section diagnosis in children.
    Arnold MA; Nicol KK
    Pediatr Dev Pathol; 2015; 18(2):139-45. PubMed ID: 25625563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of reclassifying noninvasive follicular variant of papillary thyroid carcinoma on the risk of malignancy in The Bethesda System for Reporting Thyroid Cytopathology.
    Faquin WC; Wong LQ; Afrogheh AH; Ali SZ; Bishop JA; Bongiovanni M; Pusztaszeri MP; VandenBussche CJ; Gourmaud J; Vaickus LJ; Baloch ZW
    Cancer Cytopathol; 2016 Mar; 124(3):181-7. PubMed ID: 26457584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 'Suspicious for papillary thyroid carcinoma' before and after The Bethesda System for Reporting Thyroid Cytopathology: impact of standardized terminology.
    Olson MT; Boonyaarunnate T; Altinboga AA; Ali SZ
    Acta Cytol; 2014; 58(1):15-22. PubMed ID: 24192286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of the reclassification of NIFTP as an uncertain tumour on risk of malignancy for the diagnostic categories according to the Bethesda system for reporting thyroid cytopathology.
    Kopczyński J; Suligowska A; Niemyska K; Palyga I; Walczyk A; Gąsior-Perczak D; Kowalik A; Hińcza K; Mężyk R; Góźdź S; Kowalska A
    Endokrynol Pol; 2019; 70(3):232-236. PubMed ID: 30845342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fine-Needle Aspiration Versus Frozen Section in the Evaluation of Malignant Thyroid Nodules in Patients With the Diagnosis of Suspicious for Malignancy or Malignancy by Fine-Needle Aspiration.
    Ye Q; Woo JS; Zhao Q; Wang P; Huang P; Chen L; Li X; Xu K; Yong Y; Sung-Eun Yang S; Rao J
    Arch Pathol Lab Med; 2017 May; 141(5):684-689. PubMed ID: 28447904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bethesda System Categories of Fine Needle Aspiration Cytology Are Not Associated with Thyroid Nodule Location: A Single Institution Experience.
    Xavier-Júnior JCC; Abrantkoski Borges F; Pizzello Zogheib RJ; Camilo-Júnior DJ
    Acta Cytol; 2021; 65(1):22-26. PubMed ID: 32877898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bethesda classification is a valuable guide for fine needle aspiration reports and highly predictive especially for diagnosing aggressive variants of papillary thyroid carcinoma.
    Evranos B; Polat SB; Baser H; Ozdemir D; Kilicarslan A; Yalcin A; Ersoy R; Cakir B
    Cytopathology; 2017 Aug; 28(4):259-267. PubMed ID: 27666595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New Concept of the Encapsulated Follicular Variant of Papillary Thyroid Carcinoma and Its Impact on the Bethesda System for Reporting Thyroid Cytopathology: A Single-Institute Experience.
    Canberk S; Gunes P; Onenerk M; Erkan M; Kilinc E; Kocak Gursan N; Kilicoglu GZ
    Acta Cytol; 2016; 60(3):198-204. PubMed ID: 27414983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Revised Bethesda System for Reporting Thyroid Cytology: Lessons learned from an appraisal of 5 years of experience in a central hospital.
    El Hag IA; Johnston J; Alessa E; Al Shammari M
    Cytopathology; 2021 Jul; 32(4):482-492. PubMed ID: 33772905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.